EverSource Wealth Advisors’s Anbio Biotechnology NNNN Stock Holding History

EverSource Wealth Advisors’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$195	Sell	31 -156	-83%	-$1.33K	﹤0.01%	4331
2026 Q2	$2.56K	Sell	187 -79	-30%	-$1.98K	﹤0.01%	3621
2026 Q1	$6.83K	Buy	+266	New	+$6.94K	﹤0.01%	3111

Other funds holding NNNN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

EverSource Wealth Advisors's NNNN Position: Q3 2026 in Review

EverSource Wealth Advisors reduced its Anbio Biotechnology (NNNN) stake by 83% in Q3 2026, selling an estimated $1.33K and leaving 31 shares worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #4331.

EverSource Wealth Advisors first reported a position in NNNN in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.83K in Q1 2026. 4 funds tracked by Wall St. Rank hold NNNN as of Q3 2026.

EverSource Wealth Advisors held 31 shares of Anbio Biotechnology worth $195 as of Q3 2026.
EverSource Wealth Advisors sold 156 Anbio Biotechnology shares in Q3 2026, an estimated $1.33K.
Anbio Biotechnology made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4331 holding.
EverSource Wealth Advisors first reported a position in Anbio Biotechnology in Q1 2026 and has held it in 3 quarters since.
EverSource Wealth Advisors's Anbio Biotechnology position peaked at $6.83K in Q1 2026.
4 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.